Spiral Therapeutics Closes Series A Financing Totaling $5.6 Million. New investors Sunghwan Choi and Inveready

by Inveready Asset Management

Spiral Therapeutics, a clinical stage pharmaceutical company delivering therapies for hearing loss, today announced the final closing of its Series A financing, bringing the total amount raised in thi...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Nazca Capital Acquires a Majority Stake ...

by Nazca Capital

MAD creates, produces and distributes large-scale immersive cultural e...

Photos Stream